A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2006
10/24/2006	US7125541 Administering targeting agent operatively attached to a therapeutic agent, and wherein the targeting agent recognizes and binds to a tumor-associated endothelial cell marker
10/24/2006	CA2330904C Fosinopril sodium tablet formulation
10/24/2006	CA2276587C Silicone core long term androgen delivery implant
10/24/2006	CA2275587C Injectable depot gel composition and method of preparing the composition
10/24/2006	CA2253811C Taste masked liquid suspensions
10/24/2006	CA2220682C Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
10/24/2006	CA2212744C Microcapsules of predetermined peptide(s) specificity(ies), their preparation and uses
10/24/2006	CA2073561C Polyanhydrides of the oligomerized unsaturated aliphatic acids
10/19/2006	WO2006110882A2 Hmgcoa reductase inhibitor codrugs and uses thereof
10/19/2006	WO2006110809A2 Nanoparticulate lipase inhibitor formulations
10/19/2006	WO2006110776A2 Polyethylene glycol cojugates of antimicrobial agents
10/19/2006	WO2006110476A2 Cytotoxic compounds and conjugates comprising duocarmycins with cleavable substrates
10/19/2006	WO2006110406A2 Compositions comprising probiotic and sweetener components
10/19/2006	WO2006110157A2 Nucleoside phosphonate conjugates as anti hiv agents
10/19/2006	WO2006109898A1 Antimicrobial composition containing natural extract, nano silver and natural essential oil
10/19/2006	WO2006109737A1 Pranlukast hydrate-containing preparation having relieved bitterness
10/19/2006	WO2006109734A1 External agent for treating wound
10/19/2006	WO2006109635A1 Intestinal absorptive anti-tumor agent
10/19/2006	WO2006109092A1 Conjugate comprising p21 protein for the treatment of cancer
10/19/2006	WO2006109086A2 Method to predict the sensitivity of tumors to eg5 inhibitors
10/19/2006	WO2006108719A1 Method of treating or preventing type-2 diabetes
10/19/2006	WO2006108692A2 Dosage form for oral administration of a vitamin
10/19/2006	WO2006108373A1 COMPLEXES CONSISTING OF VITAMIN D-COMPOUNDS OR ANALOGUES THEREOF HAVING A 5Z,7E,10(19)-TRIENE SYSTEM AND METHYLATED DERIVATIVES OF ß-CYCLODEXTRIN
10/19/2006	WO2006079722A3 Compositions for freeze-drying proteins
10/19/2006	WO2006078648A3 Rhinovirus vaccines
10/19/2006	WO2006074218A3 Nanoparticulate candesartan formulations
10/19/2006	WO2006060618A3 Topical nepafenac formulations
10/19/2006	WO2006046080A3 Pegylated liposomal doxorubicin in combination with ecteinescidin 743
10/19/2006	WO2006032005A3 Method and composition for preventing or treating diarrhea
10/19/2006	WO2006029150A3 Endogenously-formed conjugate of albumin
10/19/2006	WO2005103041A3 Treatment of cns disorders using cns target modulators
10/19/2006	US20060235201 Enduring T cell response
10/19/2006	US20060235084 PEG-polyacetal diblock and triblock copolymers and pharmaceutical compositions
10/19/2006	US20060235083 Controlled release drug delivery vehicle; thermogels; a topical, syringable, or injectable formulation for local controlled delivery of the active agent; therapy of damage to a retina or optic nerve
10/19/2006	US20060234995 Compositions containing piperacillin and tazobactam useful for injection
10/19/2006	US20060234980 Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
10/19/2006	US20060234979 Inclusion complex in a beta-cyclodextrin, preferably, sulfobutyl ether beta-cyclodextrin, in the form of an injectable material; reducing irritation normally caused by aripiprazole at an intramuscular injection site; for treating schizophrenia
10/19/2006	US20060234977 Antiviral compostion comprising a sulphated glucose polymer and a bacteriostatic agent
10/19/2006	US20060234942 Use of at least one $g(a)62 casein peptide with angiotensin i converting enzyme inhibiting activity for preparing medicines, food products and food complements
10/19/2006	US20060234913 Orally administering insulin and delivery agent 4-[(4-chloro, 2-hydroxybenzoyl)amino]butanoic acid that facilitates the absorption of insulin from the gastrointestinal tract; diabetes mellitus; bioavailability comparable to injection; treating diabetes without the drawbacks of systemic hyperglycemia
10/19/2006	US20060234909 Compositions and methods for increasing drug efficiency
10/19/2006	US20060234307 Fusion proteins of of Fc domains with Ang-2 binding peptides; increases biological half life; angiopoietin-2 (Ang-2)
10/19/2006	US20060233890 Method for treating a mammal by administration of a compound having the ability to release CO
10/19/2006	US20060233874 Seamless capsule
10/19/2006	US20060233869 Biocompatible, oxidized cellulose particles of specific size; and porous water soluble or water swellable polysaccharide binder; controlling post-surgical bleeding; medical equipment
10/19/2006	US20060233863 Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
10/19/2006	US20060233862 Process for the preparation of a fat composition containing sterol esters a product obtained by said process and the use thereof
10/19/2006	US20060233861 Modulation of atp production or content in the hypothalamus
10/19/2006	US20060233859 Methods for treating retinopathy with extended therapeutic effect
10/19/2006	US20060233855 Administering a synthetic polymer ( biodegradable, nonbiodegradable polymers e.g. polylactic acid, PTFE) attached to denatured, uncleaved fibrinogen being subject to proteolytic and hydrolytic degradation in a patient in need of bone tissue, thereby regenerating the bone or cartilage tissues
10/19/2006	US20060233854 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
10/19/2006	US20060233841 Implantable gel compositions and method of manufacture
10/19/2006	US20060233813 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith
10/19/2006	US20060233811 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/19/2006	US20060233802 Tumour necrosis factor binding ligands
10/19/2006	US20060233800 Biological products
10/19/2006	US20060233794 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
10/19/2006	US20060233790 Immunoglobulin/hydrophilic peptide complexes
10/19/2006	US20060233783 Topical composition in the form of a gel for treating skin burns
10/19/2006	US20060233778 Stability for injection solutions
10/19/2006	US20060233746 N-terminally chemically modified protein compositions and methods
10/19/2006	US20060233724 Medicinal composition for peridontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient
10/19/2006	US20060233719 Delivery of antidepressants through an inhalation route
10/19/2006	US20060233718 heating drugs used for the treatment of anxiety or insomnia, coated on solid supports to form vapors and condensing the vapor to form aerosols comprising microstructure particles of the drugs
10/19/2006	US20060233714 Use of a volatile liquid at atmospheric pressure and ambient temperature for the production of pharmaceutical or biological compositions
10/19/2006	US20060233712 Magnetic nanoparticles
10/19/2006	US20060233707 Process for producing an injectable medicament preparation
10/19/2006	US20060231107 Antibody-targeted photodynamic therapy
10/19/2006	DE202004021098U1 Pre-metered dry powder inhaler for moisture-sensitive medicaments e.g. tiotropium medicament, comprises dry powder medicament dose and container
10/19/2006	DE102005016873A1 New nano-particle useful for production of composition to treatment and/or prophylaxis of proliferative illnesses, cancer and bacterial infections, where nano-particle is bonded therapeutic substance
10/19/2006	DE102005015558A1 Kosmetische Zubereitung mit leichtem Hautgefühl Cosmetic composition with light skin feel
10/19/2006	CA2604835A1 Compositions comprising probiotic and sweetener components
10/19/2006	CA2604536A1 Conjugate comprising p21 protein for the treatment of cancer
10/19/2006	CA2604399A1 Variant forms of urate oxidase and use thereof
10/19/2006	CA2604077A1 Method of treating or preventing type-2 diabetes
10/19/2006	CA2603860A1 Cytotoxic compounds and conjugates comprising duocarmycins with cleavable substrates
10/19/2006	CA2574514A1 Phosphonate analogs of hiv inhibitor compounds
10/18/2006	EP1712240A1 Stable water-based medicinal preparation containing antibody
10/18/2006	EP1712237A2 Erythropoietin solution preparation stabilized with leucine, glutamic acid or lysine
10/18/2006	EP1712233A1 Aqueous solution containing pyrazoloacridone derivative
10/18/2006	EP1712223A1 Pharmaceutical preparation of recombinant factor VIII lyophilized without albumin as a stabilizer
10/18/2006	EP1712222A2 Pharmaceutical compositions providing enhanced drug concentrations
10/18/2006	EP1712221A1 Support accumulating in injured part in vascular channel
10/18/2006	EP1711595A2 Use of polysulphated alginate in cellular matrices
10/18/2006	EP1711476A2 Pyrimidyl phosphonate antiviral compounds and methods of use
10/18/2006	EP1711208A2 Conjugates of amyloid proteins as vaccines for amyloid-related diseases
10/18/2006	EP1711203A1 Targeted atherosclerosis treatment
10/18/2006	EP1711182A1 Oral cyclodextrin complexes of antituberculosis drugs
10/18/2006	EP1711170A1 Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid
10/18/2006	EP1711162A1 Method for the diffusion of molecules which are insoluble in an aqueous medium and composition using said method
10/18/2006	EP1680085A4 A novel cationic lipopolymer as a biocompatible gene delivery agent
10/18/2006	EP1567146B1 Iontophoretic delivery of rotigotine for the treatment of parkinson's disease
10/18/2006	EP1339714B1 Novel sulfonamide-substituted pyrazolopyridine derivatives
10/18/2006	EP1332206B1 Recombinant alpha-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
10/18/2006	EP1283828B1 Novel polymorph v of torasemide
10/18/2006	EP1150577B1 Improved microbial preparations
10/18/2006	EP1128815B1 Process for preparing oral calcium compositions
10/18/2006	EP0974366B1 Oral pharmaceutical preparations decreased in bitterness by masking
10/18/2006	EP0778849B1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
10/18/2006	CN1849341A Polysaccharide pseudo-sponge

1 ... 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 ... 1712